Biotech and Pharmaceuticals
Pfizer (PFE) Q4 earnings report 2023
Pfizer CEO Albert Bourla talks during a press conference with European Commission President Ursula von der Leyen after a visit ...
New York AG pushing for lifetime Trump ban cites Martin Shkreli ruling
Martin Shkreli, former chief executive officer of Turing Pharmaceuticals AG, exits court in New York, US, on Wednesday, Oct. 4, ...
Johnson & Johnson (JNJ) earnings Q4 2023
The stock trading graph of Johnson & Johnson is seen on a smartphone screen. Rafael Henrique | SOPA Images | ...
US FDA approves Vertex/CRISPR gene therapy for an inherited blood disorder
The headquarters of US biopharmaceutical company Vertex Pharmaceuticals in Boston, Massachusets, on November 4, 2023. Joseph Prezioso | Afp | ...
CVS to close ‘select’ pharmacies in Target stores in the coming months
CVS Health plans to close select pharmacies inside Target stores early this year, a company spokesperson said Thursday, as retail ...
Pharma had a year full of firsts
Soumyabrata Roy | Nurphoto | Getty Images The Alzheimer’s disease space also got plenty of attention, with the approval and ...
2024 expectations for Wegovy, Ozempic, Zepbound
Demand for the drugs is unlikely to slow down in 2024, especially as treatments gradually become more accessible. Much of ...
Moderna, Merck cancer vaccine reduces risk of skin cancer return
An exterior view of Moderna’s clinical manufacturing facility. David L. Ryan | Boston Globe | Getty Images Moderna and Merck‘s ...
First CRISPR gene-editing treatment approved in U.S.
Blood sample tube with blood for Sickle Cell Screen -Test. Sickle cell blood test, abnormal hemoglobin test. Md Babul Hosen ...
U.S. poised to approve breakthrough treatment
The U.S. Food and Drug Administration is expected to approve exa-cel gene-editing treatment for sickle cell disease. Exa-cel would be ...
